Featured Research

from universities, journals, and other organizations

Screening tool may under-report malnutrition risk in hospitalized frail older people

Date:
June 20, 2014
Source:
University of Lincoln
Summary:
A number of frail, older hospital patients in the UK who are either malnourished or at risk of malnutrition may currently go unreported, according to the findings of a new clinical study. The research, which aimed to investigate and compare the ability to predict malnutrition in a group of frail, older hospital patients using current nutritional risk screening tools, concluded that the gold standard for assessing malnutrition risk in this group may not be the best tool.

A number of frail, older hospital patients in the UK who are either malnourished or at risk of malnutrition may currently go unreported, according to the findings of a new clinical study.

The research, which aimed to investigate and compare the ability to predict malnutrition in a group of frail, older hospital patients using current nutritional risk screening tools, concluded that the gold standard for assessing malnutrition risk in this group may not be the best tool.

The malnutrition universal screening tool (MUST) is currently used in all hospitals and care homes in the UK. It formulates a risk of malnutrition based upon current body mass index (BMI), known weight loss and the presence of acute disease/no nutritional intake for five days. This score partially forms the basis upon which clinical and dietetic decisions are formulated.

Researchers from the University of Lincoln, UK, and Lincoln County Hospital took their sample group of 78 from admissions to two hospital wards in Lincoln specialising in the care of frail older patients.

They compared the MUST with the mini nutritional assessment-short form (MNA-SF®), a short-form screening version using six questions, and bioelectrical impedance analysis (BIA); a commonly used method for estimating body composition, and in particular body fat mass.

Malnutrition is a serious condition associated with increased morbidity and mortality and is particularly relevant in older people, who may also be at increased risk due to changes in body composition during aging and reduction in appetite. More complications arise with the onset of acute and chronic disease.

The team discovered there was a poor match and reliability between the two tests with the MUST consistently scoring patients in a low risk category, whereas the MNA-SF scored most within 'at risk' and 'malnourished/high risk'.

Chief Investigator Dr Adrian Slee, from the University of Lincoln's School of Life Sciences, said: "The study showed clear, significant differences in the group categorisation of malnutrition risk between the MUST and the MNA-SF.

"The BIA data supports the use of the MNA-SF as a more incisive tool in this study. This preliminary data may have significant clinical implications and highlights the potential ability of the MNA-SF and BIA to accurately assess malnutrition risk over the MUST in frail older hospital patients. This may bring into question the use of the MUST as the gold standard for assessing malnutrition risk in frail older inpatients in the UK, and may suggest that a high proportion of patients either malnourished or at risk of malnutrition may currently go unreported. Further study is required as nutritional risk categorisation has a significant impact on future clinical decisions regarding diet and nutrition in older patients on hospital wards."

The current systems that are in place have no detrimental effects to patients. The team suggests that while their study group was relatively small, the findings if repeated with a larger sample group would have far-reaching clinical implications. The study leads on from previous work by Dr Adrian Slee who performed a pilot study in a nursing care home in Lincoln in association with LACE Housing in 2011-12.


Story Source:

The above story is based on materials provided by University of Lincoln. Note: Materials may be edited for content and length.


Journal Reference:

  1. Adrian Slee, Deborah Birch, David Stokoe. A comparison of the malnutrition screening tools, MUST, MNA and bioelectrical impedance assessment in frail older hospital patients. Clinical Nutrition, 2014; DOI: 10.1016/j.clnu.2014.04.013

Cite This Page:

University of Lincoln. "Screening tool may under-report malnutrition risk in hospitalized frail older people." ScienceDaily. ScienceDaily, 20 June 2014. <www.sciencedaily.com/releases/2014/06/140620103139.htm>.
University of Lincoln. (2014, June 20). Screening tool may under-report malnutrition risk in hospitalized frail older people. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140620103139.htm
University of Lincoln. "Screening tool may under-report malnutrition risk in hospitalized frail older people." ScienceDaily. www.sciencedaily.com/releases/2014/06/140620103139.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins